The Growing Federal and State Challenges of Medical Marijuana
1 MIN READ
As of October 2018 a total of 29 states and the District of Columbia currently allow for medical marijuana and cannabis programs. What implications does this pose for workers’ compensation? Our latest video covers the current legislative and regulatory trends at the state and federal levels, along with the potential implications for the workers’ compensation industry.
Six Key Concepts in Pharmacy Benefit Management
The workers' compensation industry can be complex, from keeping up with regulatory changes to understanding the roles and responsibilities of various key stakeholders. Whether you are just starting out in the industry or looking to refresh your knowledge, here are six key concepts to understand about Pharmacy Benefit Management in the workers' compensation industry.
StateWatch: Bill Review October 2018
2 MIN READ
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
When are Specialty Drugs, Biologics, and Biosimilars Used in Workers’ Compensation?
3 MIN READ
For workers’ compensation, specialty drugs are prescribed to treat conditions either directly or indirectly related to workplace injuries or illnesses. Directly related conditions, such as HIV and hepatitis, might occur when individuals are exposed to contaminated material (i.e. those working in healthcare or emergency service settings). Indirectly related conditions, such as inflammatory arthritis, are common, and the subsequent work disability and/or potential of being linked to this group of illnesses is significant. Other indirectly related conditions that could be compensable in workers’ compensation are those aggravated by a workplace injury, including multiple sclerosis. The impact specialty drugs will have on workers’ compensation claims will depend largely on the demographics of the insured population.
40 Years in Workers’ Comp: The Evolution of Technology in Medical Management
Last week, I shared news of Genex Services reaching a momentous milestone – 40 years serving the workers’ compensation industry.
The Difference Between Specialty Drugs, Biologics, and Biosimilars
3 MIN READ
In the world of workers’ comp pharmacy benefit management, understanding generics vs. brand name drugs, narcotics, muscle relaxants, and compounds now seems relatively simple as compared with the latest pharmacy terminology: specialty drugs, biologics, and biosimilars. These terms are making the headlines with increased frequency, and while some think they are interchangeable, there truly are distinctions between them.
40 Years in Workers' Comp: Looking back on Our Industry's Continuous Evolution
This month Genex Services is celebrating its 40th anniversary, a significant accomplishment in this industry. For our company and staff, it’s a momentous occasion and cause for celebration.